V-Square Quantitative Management’s Regeneron Pharmaceuticals REGN Stock Holding History

V-Square Quantitative Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$639K	Buy	1,025 +77	+8%	+$52.4K	0.06%	276
2026 Q1	$732K	Buy	948 +1	+0.1%	+$766	0.08%	221
2025 Q4	$731K	Buy	+947	New	+$643K	0.08%	221
2025 Q3	–	Sell	-1,346	Closed	-$707K	–	494
2025 Q2	$707K	Sell	1,346 -154	-10%	-$86K	0.09%	223
2025 Q1	$951K	Buy	1,500 +11	+0.7%	+$7.57K	0.14%	158
2024 Q4	$1.06M	Buy	1,489 +158	+12%	+$133K	0.15%	139
2024 Q3	$1.4M	Buy	1,331 +80	+6%	+$89K	0.21%	97
2024 Q2	$1.31M	Buy	1,251 +54	+5%	+$52.3K	0.21%	81
2024 Q1	$1.15M	Buy	1,197 +437	+58%	+$416K	0.16%	99
2023 Q4	$668K	Buy	760 +310	+69%	+$255K	0.12%	147
2023 Q3	$370K	Buy	450 +249	+124%	+$196K	0.16%	146
2023 Q2	$144K	Sell	201 -73	-27%	-$56.3K	0.11%	177
2023 Q1	$225K	Buy	+274	New	+$207K	0.21%	119

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

V-Square Quantitative Management's REGN Position: Q2 2026 in Review

V-Square Quantitative Management increased its Regeneron Pharmaceuticals (REGN) stake by 8.1% in Q2 2026, buying an estimated $52.4K and bringing the position to 1,025 shares worth $639K. The position accounts for 0.06% of the portfolio, ranked #276.

V-Square Quantitative Management first reported a position in REGN in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.4M in Q3 2024. 469 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

V-Square Quantitative Management held 1,025 shares of Regeneron Pharmaceuticals worth $639K as of Q2 2026.
V-Square Quantitative Management bought 77 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $52.4K.
Regeneron Pharmaceuticals made up 0.06% of V-Square Quantitative Management's portfolio in Q2 2026, its #276 holding.
V-Square Quantitative Management first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
V-Square Quantitative Management's Regeneron Pharmaceuticals position peaked at $1.4M in Q3 2024.
469 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.